Beta Drugs P/B Ratio

Beta Drugs (BETA) P/B ratio is 6.2 (High), book value per share ₹197.00 vs Healthcare average P/B of -0.18 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see BETA company profile.

Current P/B Ratio
6.2
High Valuation
Very High - Significant premium, high growth expectations or speculative

Current Valuation Metrics

P/B Ratio 6.2
Current Price ₹1386.60
Book Value/Share ₹197.00
Exchange NSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹197 Cr
Share Capital ₹10 Cr
Reserves & Surplus ₹187 Cr
Outstanding Shares 10,000,000
Book Value per Share ₹197.00

Valuation Signal

Signal Overvalued
Historical Avg 7.86
Historical Range 7.86 - 7.86
Percentile 0.0%

Sector Context

Sector Average -0.18
Sector Median 0.67
Sector Rank #11 of 50
Sector Percentile 22.0%

BETA P/B Ratio — Valuation Insights & Book Value Analysis

Beta Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 6.2 (High). Check Beta Drugs market cap to track the company's total market size over time.

  • Stock appears overvalued with PB of 6.2, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 21.1% below historical average
  • Trading at premium to sector average PB of -0.18

Beta Drugs P/B Ratio Historical Trend

BETA annual price-to-book ratio — 1 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Also explore Beta Drugs share price performance to track price trends across different timeframes.

BETA Historical P/B Ratio — Book Value Per Share & Year-End Price

Beta Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 7.86 ₹197.0 ₹1549.10 ₹197 High

BETA vs Healthcare Peers — P/B Ratio Comparison

Beta Drugs P/B 6.2 vs Healthcare average -0.18, median 0.67 — range -13.75–1.1.

Sector Average
-0.18
Sector Median
0.67
Lowest P/B
-13.75
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Sun Pharma Advanced Rese… SPARC -13.75 ₹4,814 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.47 ₹95 Low
Parmax Pharma PARMAX -2.15 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.96 ₹154 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Triochem Products TRIPR 0.04 ₹0 Low